NGNE Competitors & Alternatives
Compare Neurogene Inc with similar stocks in the same industry
Biotechnology
NGNE
Main Stock$28.78
Tradestie Score
61
Market Cap
$256.54M
Analyst Upside
+178.0%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PRTA
Prothena Corporation plc Ordinary Shares
|
$10.02
|
$533.99M | - | 56 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$10.87
|
$529.35M | 5.8 | 63 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.17
|
$512.39M | - | 60 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$28.74
|
$505.12M | 1.7 | 60 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$108.04
|
$492.21M | - | 54 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$41.73
|
$474.20M | 26.8 | 53 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$4.97
|
$468.01M | - | 58 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$18.50
|
$463.20M | - | 54 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$6.84
|
$457.09M | - | 52 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$4.18
|
$454.29M | - | 58 | Compare |
More NGNE Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry